Industry
6430 Trusts, funds and similar financial entities

VCID: 427666
Profile

Corporate information


Registration country
Investment activity status
Active investor

Selected investments

Country Date Notes
ACT Genomics Co Ltd
Provider of cancer molecular information solutions. 		Taiwan 6 May 2016 Series B
Follow-on investment. Round participant. Active

DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.